NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
Formulary Chapter: 6 - Endocrine system 
Notes:

Any drug not listed on the Formulary should be considered Non-Formulary - Not recommended for prescribing

06.01.02.01 Sulphonyureas

Gliclazide 40mg, 80mg
(Tablets)

First Choice

First choice sulphonylurea

Entry reviewed: September 2023

Glibenclamide 2.5mg, 5mg
(Tablets)

Restricted Drug Restricted

Restricted - New Patients are not to be started on this medication due to long half life and risk of hypoglycemia

Gliclazide MR 30mg, 60mg
(Tablets)

Formulary

Entry reviewed: September 2023

Glimepiride 1mg, 2mg, 3mg, 4mg
(Tablets)

Formulary

Tolbutamide 500mg
(Tablets)

Restricted Drug Restricted

Restricted - Not to be used as a first choice treatment due to drug interactions.

Classifications
May be initiated in any care setting
Specialist to advise therapy and provide first 28 days supply, continuation in Primary Care
Specialist to initiate and stabilise medicine prior to continuation in Primary Care
To be prescribed as per Shared Care Guidance. If no SCG in place status reverts to red.
Red medicines are designated as specialist only medicines which should only be prescribed by a specialist, usually within secondary care (either due to the requirement for specialist knowledge, long-term monitoring requirements, or restrictions that mean medicine supplies are only available to hospitals).
A decision has been made either locally and/or nationally not to routinely commission this preparation. Do not prescribe.
To be purchased over the counter. May be prescribed for chronic, long term conditions or on admission to hospital if essential.